- Home
- CHNR vs AEON Comparison
CHNR vs AEON Comparison
Compare CHNR & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- AEON
- Stock Information
- Founded
- CHNR N/A
- AEON N/A
- Country
- CHNR Hong Kong
- AEON United States
- Employees
- CHNR N/A
- AEON N/A
- Industry
- CHNR Precious Metals
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- CHNR Basic Materials
- AEON Health Care
- Exchange
- CHNR Nasdaq
- AEON Nasdaq
- Market Cap
- CHNR 4.8M
- AEON 4.2M
- IPO Year
- CHNR 1995
- AEON N/A
- Fundamental
- Price
- CHNR $0.57
- AEON $0.46
- Analyst Decision
- CHNR
- AEON Strong Buy
- Analyst Count
- CHNR 0
- AEON 1
- Target Price
- CHNR N/A
- AEON $360.00
- AVG Volume (30 Days)
- CHNR 13.5K
- AEON 465.0K
- Earning Date
- CHNR 01-01-0001
- AEON 05-13-2025
- Dividend Yield
- CHNR N/A
- AEON N/A
- EPS Growth
- CHNR N/A
- AEON N/A
- EPS
- CHNR N/A
- AEON 72.93
- Revenue
- CHNR N/A
- AEON N/A
- Revenue This Year
- CHNR N/A
- AEON N/A
- Revenue Next Year
- CHNR N/A
- AEON N/A
- P/E Ratio
- CHNR N/A
- AEON $0.01
- Revenue Growth
- CHNR N/A
- AEON N/A
- 52 Week Low
- CHNR $0.45
- AEON $0.38
- 52 Week High
- CHNR $1.14
- AEON $402.48
- Technical
- Relative Strength Index (RSI)
- CHNR 55.22
- AEON 26.87
- Support Level
- CHNR $0.45
- AEON $0.38
- Resistance Level
- CHNR $0.55
- AEON $0.43
- Average True Range (ATR)
- CHNR 0.05
- AEON 0.04
- MACD
- CHNR 0.01
- AEON 0.20
- Stochastic Oscillator
- CHNR 78.20
- AEON 56.29
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.